Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Centre for Biological Threats and Special Pathogens 1 - Highly Pathogenic Viruses & German Consultant Laboratory for Poxviruses & WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany.
Vaccine. 2017 Dec 19;35(52):7222-7230. doi: 10.1016/j.vaccine.2017.11.003. Epub 2017 Nov 11.
For almost 150 years after Edward Jenner had published the "Inquiry" in 1798, it was generally assumed that the cowpox virus was the vaccine against smallpox. It was not until 1939 when it was shown that vaccinia, the smallpox vaccine virus, was serologically related but different from the cowpox virus. In the absence of a known natural host, vaccinia has been considered to be a laboratory virus that may have originated from mutational or recombinational events involving cowpox virus, variola viruses or some unknown ancestral Orthopoxvirus. A favorite candidate for a vaccinia ancestor has been the horsepox virus. Edward Jenner himself suspected that cowpox derived from horsepox and he also believed that "matter" obtained from either disease could be used as preventative of smallpox. During the 19th century, inoculation with cowpox (vaccination) was used in Europe alongside with inoculation with horsepox (equination) to prevent smallpox. Vaccine-manufacturing practices during the 19th century may have resulted in the use of virus mixtures, leading to different genetic modifications that resulted in present-day vaccinia strains. Horsepox, a disease previously reported only in Europe, has been disappearing on that continent since the beginning of the 20th century and now seems to have become extinct, although the virus perhaps remains circulating in an unknown reservoir. Genomic sequencing of a horsepox virus isolated in Mongolia in 1976 indicated that, while closely related to vaccinia, this horsepox virus contained additional, potentially ancestral sequences absent in vaccinia. Recent genetic analyses of extant vaccinia viruses have revealed that some strains contain ancestral horsepox virus genes or are phylogenetically related to horsepox virus. We have recently reported that a commercially produced smallpox vaccine, manufactured in the United States in 1902, is genetically highly similar to horsepox virus, providing a missing link in this 200-year-old mystery.
近 150 年来,自从爱德华·詹纳(Edward Jenner)于 1798 年出版《调查》("Inquiry")以来,人们普遍认为牛痘病毒是预防天花的疫苗。直到 1939 年,人们才发现,天花疫苗病毒——痘苗病毒,在血清学上是相关的,但与牛痘病毒不同。由于没有已知的天然宿主,痘苗病毒被认为是一种实验室病毒,它可能起源于涉及牛痘病毒、天花病毒或某些未知祖先正痘病毒的突变或重组事件。痘苗病毒的一个备受青睐的祖先候选者是马痘病毒。爱德华·詹纳本人怀疑牛痘源自马痘,他还认为,从任何一种疾病中获得的“物质”都可以用来预防天花。在 19 世纪,欧洲同时使用牛痘(接种)和马痘(接种)来预防天花。19 世纪的疫苗制造实践可能导致使用病毒混合物,导致不同的遗传修饰,从而产生了当今的痘苗病毒株。马痘,一种以前仅在欧洲报告过的疾病,自 20 世纪初以来一直在欧洲大陆消失,现在似乎已经灭绝,尽管这种病毒可能仍在未知的宿主中传播。1976 年在蒙古分离的马痘病毒的基因组测序表明,尽管与痘苗病毒密切相关,但这种马痘病毒含有痘苗病毒中不存在的额外的潜在祖先序列。对现存痘苗病毒的最近遗传分析表明,一些毒株含有祖先马痘病毒基因,或者与马痘病毒在系统发育上有关。我们最近报告称,美国于 1902 年生产的一种商业天花疫苗在遗传上与马痘病毒非常相似,为这个 200 年的谜团提供了一个缺失的环节。